text
stringlengths 15
247
|
|---|
Uterine cervix, colposcopic biopsy;
Invasive squamous cell carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
|
Uterine cervix, punch biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Lung, biopsy;
Adenocarcinoma
|
Lung, biopsy;
Adenocarcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
Invasive squamous cell carcinoma
|
Lung, biopsy;
Adenocarcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 90%
|
Uterine cervix, punch biopsy;
Invasive squamous cell carcinoma
|
Colon, colonoscopic biopsy;
Signet-ring cell carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, well differentiated
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Colon, colonoscopic biopsy;
Mucinous carcinoma
|
Rectum, colonoscopic biopsy;
Neuroendocrine tumor, G1
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
with glandular involvement
|
Lung, biopsy;
Adenocarcinoma
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 5%
|
Colon, colonoscopic biopsy;
Adenocarcinoma, poorly differentiated
|
Colon, colonoscopic biopsy;
Adenocarcinoma, well differentiated with mucinous component
|
Lung, biopsy;
Small cell carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Colon, colonoscopic biopsy;
Mucinous carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 80%
|
Uterine cervix, colposcopic biopsy;
Endocervical adenocarcinoma in situ (AIS), HPV-associated
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Lung, biopsy;
Adenocarcinoma
|
Lung, biopsy;
No evidence of malignancy or granuloma
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Uterine cervix, punch biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 90%), tumor volume: 60%
|
Uterine cervix, punch biopsy;
Invasive squamous cell carcinoma
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 100%
|
Colon, colonoscopic biopsy;
Adenocarcinoma, poorly differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 25%
|
Rectum, colonoscopic biopsy;
Chronic nonspecific inflammation
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 70%
|
Lung, biopsy;
No evidence of malignancy or granuloma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Lung, biopsy;
Squamous cell carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 70%
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
with glandular involvement
|
Lung, biopsy;
Non-small cell carcinoma, favor squamous cell carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Lung, biopsy;
Squamous cell carcinoma
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 40%), tumor volume: 90%
|
Rectum, colonoscopic biopsy;
Chronic nonspecific inflammation
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 10%), tumor volume: 60%
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Lung, biopsy;
Squamous cell carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, punch biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 80%), tumor volume: 40%
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 100%
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Lung, biopsy;
Chronic granulomatous inflammation with necrosis
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
Chronic nonspecific cervicitis with squamous metaplasia
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
with glandular involvement
|
Uterine cervix, colposcopic biopsy;
Chronic nonspecific cervicitis
|
Urinary bladder, transurethral resection;
1. No tumor present
2. Chronic granulomatous inflammation with foreign body reaction
Note) The specimen includes muscle proper.
|
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of muscle proper
Note) The specimen includes muscle proper.
|
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, low grade
Note) The specimen includes muscle proper.
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 5%
|
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
Note) The specimen includes muscle proper.
|
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, high grade
Note) The specimen includes muscle proper.
|
Urinary bladder, transurethral resection;
1. Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
2. Urothelial carcinoma in situ
Note) The specimen does not include muscle proper.
|
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of muscle proper
Note) The specimen includes muscle proper.
|
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, high grade
Note) The specimen includes muscle proper.
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 10%
|
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
Note) The specimen does not include muscle proper.
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 9 (5+4), grade group 5, tumor volume: 100%
|
Prostate, biopsy;
No tumor present
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 30%), tumor volume: 90%
|
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, low grade
Note) The specimen includes muscle proper.
|
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, low grade
Note) The specimen includes muscle proper.
|
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
Note) The specimen includes muscle proper.
|
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, high grade
Note) The specimen includes muscle proper.
|
Prostate, biopsy;
No tumor present
|
Lung, biopsy;
Chronic granulomatous inflammation with necrosis
|
Urinary bladder, transurethral resection;
1. Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
2. Urothelial carcinoma in situ
Note) The specimen includes muscle proper.
|
Lung, biopsy;
Small cell carcinoma
|
Prostate, biopsy;
No tumor present
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.